Andes Technology Corporation (TPE:6533)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,625	20,995	24,312	25,199	27,149	14,245
Market Cap Growth	-25.99%	-13.65%	-3.52%	-7.18%	90.58%	153.03%
Enterprise Value	11,863	18,881	20,995	20,865	23,036	13,671
Last Close Price	269.00	414.50	480.00	495.97	528.86	329.01
PE Ratio	-	11090.78	-	70.80	167.93	405.37
Forward PE	105.74	106.87	270.85	-	-	-
PS Ratio	9.46	15.20	22.98	27.04	33.12	24.52
PB Ratio	2.89	4.36	5.05	5.05	5.69	11.92
P/TBV Ratio	5.30	7.36	6.62	5.76	6.18	15.74
P/FCF Ratio	42.48	57.09	-	38.28	89.83	133.28
P/OCF Ratio	41.94	56.41	-	35.09	87.21	129.29
EV/Sales Ratio	8.24	13.67	19.85	22.39	28.10	23.53
EV/EBITDA Ratio	71.76	176.25	-	195.30	80.04	113.25
EV/EBIT Ratio	-	-	-	-	145.19	363.38
EV/FCF Ratio	36.99	51.35	-	31.70	76.22	127.90
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.09
Debt / EBITDA Ratio	0.50	0.63	-	0.70	0.32	0.79
Debt / FCF Ratio	0.26	0.24	-	0.13	0.32	1.02
Asset Turnover	0.28	0.26	0.20	0.18	0.26	0.42
Inventory Turnover	0.20	0.22	0.38	0.44	0.94	0.66
Quick Ratio	9.21	7.36	8.64	13.56	25.40	8.27
Current Ratio	9.48	7.58	9.04	13.78	25.67	8.48
Return on Equity (ROE)	-1.31%	0.04%	-2.08%	7.29%	5.42%	2.97%
Return on Assets (ROA)	-3.00%	-3.24%	-3.12%	-0.83%	3.08%	1.68%
Return on Capital (ROIC)	-3.19%	-3.51%	-3.36%	-0.87%	3.21%	1.80%
Return on Capital Employed (ROCE)	-	-	-	-	3.30%	2.90%
Earnings Yield	-0.45%	0.01%	-0.42%	1.41%	0.60%	0.25%
FCF Yield	2.35%	1.75%	-0.49%	2.61%	1.11%	0.75%
Dividend Yield	-	-	-	0.30%	0.54%	0.22%
Payout Ratio	-	-	-	40.54%	19.56%	41.28%
Buyback Yield / Dilution	-	-	0.39%	-12.78%	-5.69%	-0.00%
Total Shareholder Return	-	-	0.39%	-12.48%	-5.15%	0.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.